Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CRIXlabs Joins the ROCK Health Incubator: ROCK Health is the world’s leading healthcare incubator looking to make meaningful change through scalable, innovative technology.

Abstract:
CRIXlabs, Inc. today announced joining the ROCK Health incubator located in San Francisco, CA. CRIXlabs is the creator of NuSilico, the #1 predictive nanoparticle software used by Pharma.

CRIXlabs Joins the ROCK Health Incubator: ROCK Health is the world’s leading healthcare incubator looking to make meaningful change through scalable, innovative technology.

San Diego, CA | Posted on June 5th, 2013

"We couldn't be more excited to be part of the family over at ROCK Health" said Jon Stenstrom, CRIXlabs' CEO and Co-Founder. "CRIXlabs' NuSilico software enables pharmaceutical companies to create more effective treatments with reduced side-effects, for cancer and a wide variety of other diseases." Jon has a strong healthcare product development background and holds a Master of Engineering from San Diego State University.

The CRIXlabs team includes Dr. Shalini Ananda, CTO and Co-Founder with expertise in software development and nanotechnology and Dr. Garrett Smith, Co-Founder and advisor, a serial entrepreneur with expertise in nanoparticle synthesis and a former Stanford BioDesign Fellow; both of which received their PhDs from the University of California, San Diego.

The ROCK Health announcement: rockhealth.com/2013/06/new-class-new-partners-new-space/

####

About CRIXlabs, Inc.
Creators of NuSilico, the #1 predictive nanoparticle software used by Pharma.

NuSilico increases the probability of finding the next blockbuster drug. Today, Pharma uses NuSilico to identify unfavorable nanotherapeutic candidates early, potentially saving years of development time and millions of dollars. NuSilico can optimize nanoparticle platforms, increasing their ability to treat diseases such as cancer more effectively and with lower side-effects.

CRIXlab’s unique background in software, nanoparticle synthesis, and imaging helps researchers look at all possible scenarios prior to beginning pre-clinical trials.

NuSilico uses a proprietary database and algorithms to determine the biodistribution and half-life of nanoparticle platforms prior to expensive preclinical trials. Early identification helps ensure the research process is efficient and cost-effective for the client.

CRIXlabs has been accepted into the ROCK Health incubator in San Francisco and have terms on the table with Kleiner Perkins, Mohr Davidow, Aberdare Ventures, and the Mayo Clinic.

They have begun working with a Top 10 Pharmaceutical company on their nanoparticle platforms. They are in active discussions with the Top 5 Pharmaceutical companies for the use of their software.

For more information, please click here

Contacts:
Jon Stenstrom, MEng.
Co-Founder & CEO
CRIXlabs, Inc.
858-598-4272

Copyright © CRIXlabs, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nano 'sandwich' offers unique properties: Rice University researchers simulate two-dimensional hybrids for optoelectronics February 27th, 2017

Dream Chip Technologies Presents First 22nm FD-SOI Silicon of New Automotive Driver Assistance SoC: Advanced driver assistance system (ADAS) computer vision SoC developed for European THINGS2DO project with working first silicon fabricated on GLOBALFOUNDRIES’ 22nm FD-SOI Platfor February 27th, 2017

Sandia use confined nanoparticles to improve hydrogen storage materials performance: Big changes from a small package for hydrogen storage February 25th, 2017

New nano approach could cut dose of leading HIV treatment in half February 24th, 2017

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund January 24th, 2017

Harris & Harris Group Issues Reminder for Shareholder Update Call on January 10, 2017 January 10th, 2017

Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016

Harris & Harris Group Issues Letter to Shareholders and Information for Shareholder Call on Tuesday, November 15, 2016 November 14th, 2016

Software

Nanomechanics Inc. Continues Growth in Revenue and Market Penetration: Leading nanoindentation company reports continued growth in revenues and distribution channels on national and international scales December 27th, 2016

Companies Now Can Bring Fast and Accurate Nanoparticle Analysis In-House November 11th, 2016

Announcements

Nano 'sandwich' offers unique properties: Rice University researchers simulate two-dimensional hybrids for optoelectronics February 27th, 2017

Dream Chip Technologies Presents First 22nm FD-SOI Silicon of New Automotive Driver Assistance SoC: Advanced driver assistance system (ADAS) computer vision SoC developed for European THINGS2DO project with working first silicon fabricated on GLOBALFOUNDRIES’ 22nm FD-SOI Platfor February 27th, 2017

Sandia use confined nanoparticles to improve hydrogen storage materials performance: Big changes from a small package for hydrogen storage February 25th, 2017

New nano approach could cut dose of leading HIV treatment in half February 24th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project